Navigation Links
Medarex Announces 2008 First Quarter Financial Results
Date:5/12/2008

PRINCETON, N.J., May 12 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today its financial results for the quarter ended March 31, 2008.

Including a gain of $151.8 million, or $1.19 per share, from Medarex's sale of 2.5 million shares of Genmab A/S stock in February 2008, Medarex's net income for the quarter ended March 31, 2008, was $103.3 million, or $0.81 per share, as compared to a net income of $110.3 million, or $0.88 per share for the same period in 2007. In addition to the gain on the sale of Genmab A/S stock, Medarex's net income for the quarter ended March 31, 2008 included a loss of $2.9 million, or ($0.02) per share, representing Medarex's share of the 2008 net loss of Celldex Therapeutics, Inc. (a subsidiary of Medarex) prior to its merger with AVANT Immunotherapeutics, Inc., and a non-cash charge of $5.3 million, or ($0.04) per share, for stock-based compensation recorded in accordance with FAS 123(R). Excluding the impact of these items, Medarex's net loss on a non-GAAP basis for the first quarter of 2008 was $38.5 million, or ($0.30) per share.

Total revenues for the quarter ended March 31, 2008, were $12.0 million as compared to $11.5 million in 2007.

Research and development (R&D) expenses for the quarter ended March 31, 2008, increased by $2.3 million, from $47.0 million in 2007 to $49.3 million in 2008. General and administrative expenses increased by $1.1 million for the quarter ended March 31, 2008, from $11.3 million in 2007 to $12.4 million in 2008.

Medarex ended the first quarter of 2008 with approximately $464.5 million in cash, cash equivalents and marketable securities. In addition, the fair market value of Medarex's equity interest in Genmab was approximately $115.
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
2. Medarex Announces 2007 Fourth Quarter and Year End Financial Results
3. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
4. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
5. PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
6. Medarex to Present at the JPMorgan Small/Mid Cap Conference
7. Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
8. Medifast Announces First Quarter 2008 Financial Results
9. Esperanza Announces Support of H.R. 1108, Encourages Congress to Pass FDA Regulation of Tobacco
10. Pregis Announces First Quarter 2008 Financial Results
11. Almost Family, Inc. Announces Exercise of Over-Allotment Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... By Randy Dotinga ... -- Women who have the largest number of post-traumatic stress ... an addiction to food, a new study suggests. ... women overeating or becoming addicted to food. And it,s also ... experiencing trauma, PTSD, or both. Still, the research ...
(Date:9/18/2014)... 18, 2014 How much is a ... of the factors contributing to the obesity epidemic in ... single serving and how to manage portion size during ... Oct. 3 at Humility House, 755 Ohltown Road, Austintown. ... lead the informational discussion and answer questions from 12:30 ...
(Date:9/18/2014)... Texas Physical Therapy Specialists (TexPTS) is proud to ... Association (HPA) Friends and Family Golf tournament on ... tournament, which will take place at TopGolf from 9 ... through three golf challenges, “Top Scramble”, “Top Score”, and ... provided at the event and there will be open ...
(Date:9/18/2014)... Eye doctors have long known that staring ... basal tear film in the eyes to lose water and ... that staring at a computer screen can also alter the ... about computers, the tear film and dry eye for years ... (*Gray, Sarah, “Staring at Screen is Altering Your Tears, Study ...
(Date:9/18/2014)... 18, 2014 Members of United ... participating network dentists at UnitedConcordia.com, thanks to a ... company. , "Members can book an appointment with ... button located on the Find a Dentist page ... of network operations at United Concordia. "We are ...
Breaking Medicine News(10 mins):Health News:PTSD Link to Food Addiction Seen in Report 2Health News:PTSD Link to Food Addiction Seen in Report 3Health News:HMHP Workshop Addresses Portion Control 2Health News:Texas Physical Therapy Specialists Sponsoring HPA Friends & Family Golf Tournament 2Health News:New Study Confirms that Staring at a Computer Screen Alters Tear Film Content and Causes Dry Eye 2Health News:New Study Confirms that Staring at a Computer Screen Alters Tear Film Content and Causes Dry Eye 3Health News:United Concordia Offers Real-time Online Scheduling for their Members, Through LocalMed 2Health News:United Concordia Offers Real-time Online Scheduling for their Members, Through LocalMed 3
... , , LEXINGTON, Ky., Sept. ... stopping in Kentucky throughout the week of September 8 - 11 ... access information on programs that provide prescription medicines for free or ... -- one of the worst rates in the nation -- the ...
... BATESVILLE, Ind., Sept. 4 Hill-Rom Holdings, Inc. (NYSE: ... $0.1025 per share. This dividend was declared by Hill-Rom,s Board of ... to shareholders of record as of September 16, 2009. , , ... is a leading worldwide manufacturer and provider of medical technologies and related ...
... , , , DETROIT, Sept. ... Daniel J. Loepp made the following statement in conjunction with the ... with a serious illness. , , Blue Cross ... to jointly announce Mr. Harwell,s retirement as Blue Cross,s health and ...
... , , , ... Dk hybrid contact lens manufacturer, recently introduced a new ... revolutionary contact lens that takes advantage of the best ... centration, stability, and all-day comfort. The patent-pending design is ...
... , NEW HAVEN, Conn., Sept. 4 ... development and commercialization of novel antibiotics for the treatment of ... has joined the company as Chief Business Officer. In his ... activities. , , Mr. Kassberg, age 49, ...
... , NEW YORK, Sept. 4 Delcath Systems, ... its proprietary treatment method for primary and metastatic cancers to the ... make a presentation to investors at the Rodman & Renshaw 11th ... Time in New York. Mr. Hobbs will review the Company,s business ...
Cached Medicine News:Health News:Partnership for Prescription Assistance Prepared to Help Kentucky Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Kentucky Workers Hurt by Recession 3Health News:SynergEyes, Inc. Expands Launch of New Hybrid Contact Lens Design for Keratoconus Patients 2Health News:Rib-X Pharmaceuticals, Inc. Appoints Tom Kassberg Chief Business Officer 2
(Date:9/18/2014)... MELBOURNE, Australia , Sept. 18, 2014 /PRNewswire/ ... the appointments of Dr. Ashraf Hanna , M.D., ... to its Board of Directors. Dr. Hanna is the ... Genentech and Chief Financial Officer for the Genentech Foundation, ... and Global Head of Business Development and Licensing for ...
(Date:9/18/2014)... Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage ... pain, announced today that it has appointed Mr. ... Director of Clinical Development. During his extensive ... led successful global clinical operations teams, in the US ... clinical development of numerous therapeutics and diagnostics across a ...
(Date:9/18/2014)... /CNW/ - A new expert panel report, Improving Medicines ... released today by the Council of Canadian Academies, addresses ... children. Each year about half of Canada,s ... prescription drug. Much of this prescribing is done off-label ... potential health risks. Children have historically been ...
Breaking Medicine Technology:Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 3
... publication in prominent peer-reviewed journal highlights,findings of ... infection, EVANSTON, Ill., March 17 ... using a,rapid molecular diagnostic test is effective ... published in the Annals of Internal Medicine,by ...
... on Track to Initiate Phase 2b in Second Quarter ... - Conference Call Tomorrow at 8:00 a.m. ... Ardea Biosciences, Inc.,(Nasdaq: RDEA ) today announced positive ... RDEA806, its novel,investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), in,patients ...
Cached Medicine Technology:Evanston Northwestern Healthcare Researchers Explain Effects of Large-Scale, Universal MRSA Surveillance Program That Supports Expanded Intervention 2Evanston Northwestern Healthcare Researchers Explain Effects of Large-Scale, Universal MRSA Surveillance Program That Supports Expanded Intervention 3Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 2Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 3Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 4
... hands play an important part in our ... and rheumatic changes can cause severe handicaps. ... the finger-joint prostheses was to produce a ... natural function as nearly possible.,The cementless RM ...
... hands play an important part in our ... and rheumatic changes can cause severe handicaps. ... the finger-joint prostheses was to produce a ... natural function as nearly possible.,The cementless RM ...
... precise control of the thigh during varus/valgus manipulation ... the proximal thigh during ACL or PCL procedures. ... on both right and left legs and may ... Holder can be used with an Arthrex tourniquet ...
... for trauma, foot and ankle or deformity ... External Fixation components are designed to reduce ... the complexity of intra-operative and post-operative frame ... and hinges eliminate the need to stock ...
Medicine Products: